國家衛生研究院 NHRI:Item 3990099045/11212
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12189/12972 (94%)
造访人次 : 954106      在线人数 : 746
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11212


    题名: Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors
    作者: Shiao, HY;Wang, WC;Hsu, YC;Ke, YY;Hsu, TA;Hsieh, HP
    贡献者: Institute of Biotechnology and Pharmaceutical Research
    摘要: Since the launch of Gleevec in 2001, protein kinases have emerged as attractive therapeutic targets for the treatment of various cancers. One of these, anaplastic lymphoma kinase (ALK), has attracted a great deal of attraction due to its oncogenic potential and essential role in the pathogenesis of a wide variety of human cancers, such as ALCLs, NSCLC, breast cancer, colorectal cancer, neuroblastoma, ovarian cancer, etc. Currently, seven ALK inhibitors have been approved under clinical investigation and two inhibitors, crizotinib and ceritinib, were approved by FDA for the treatment of locally advanced and ALK-positive metastatic NSCLC patients who were previously treated with-, or intolerant to crizotinib respectively. Therefore, the development of ALK inhibitors targeting the ATP binding site could be a tremendous interest for the treatment of ALK-driven cancers. In this study, we screened in-house library of 350 furanopyrimidines for vitro enzyme-based testing of ALK inhibition at 10 mM and BPR4K0050S0 bearing a unique (4-hydroxyphenethyl)amino substituent possessed 62% inhibition. The further structural modification with the objectives of improving the potency based on structure biology and docking studies. A promising compound, BPR4K0059S0 with 2,4-diaminopyrimidine scaffold, exhibited inhibitory activity against ALKWT and ALKL1196M with IC50 values of 142 nM and 193 nM respectively, and showed anti-proliferation activity against KARPAS-299 cell line with an IC50 value of 328 nM.
    日期: 2015-08
    關聯: Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 182.
    Link to: https://www.acs.org/content/acs/en/meetings/national-meeting/about/meetings-archive.html
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000432475701336
    显示于类别:[謝興邦] 會議論文/會議摘要
    [徐祖安] 會議論文/會議摘要
    [王文傑] 會議論文/會議摘要

    文件中的档案:

    档案 大小格式浏览次数
    ISI000432475701336.pdf91KbAdobe PDF981检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈